Oops! This Content is Members Only

Recent Content

• Salvage Therapy for Amyloidosis in Multiple Myeloma: Agents and Anti-Fibril Therapy
• Myeloma research on the move
• Dr. van Rhee on the Clinical Implications of CAR T-Cell Therapy in Relapsed/Refractory Myeloma
• Dr. Patel on Mitigating CAR T-Cell Therapy­–Related CRS in Multiple Myeloma
• Dr. Baljevic on the FDA Approval of the ICARIA-MM Regimen in Relapsed/Refractory Multiple Myeloma
• Dr. Anderson on the Challenges Faced With CAR T-Cell Therapy in Myeloma
• Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial
• Dr. Shah on the Current State of Cellular Therapy in Multiple Myeloma
• Updates in Sequencing Treatment for Early Multiple Myeloma Relapse
• Dr. Shah on Unmet Needs With CAR T-Cell Therapy in Multiple Myeloma